Clinical effects of Juming Jiangya pill combined with amlodipine besylate in treatment of essential hypertension
10.3969/j.issn.1005-1678.2017.07.038
- VernacularTitle:菊明降压丸联合苯磺酸氨氯地平治疗原发性高血压的临床研究
- Author:
Jing ZHANG
;
Xiaoling TIAN
;
Baohai XU
- Keywords:
Juming Jiangya pill;
amlodipine besylate;
essential hypertension
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(7):101-103
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyse clinical effects of Juming Jiangya pill combined with amlodipine besylate in treatment of essential hypertension.Methods 126 patients with essential hypertension from August 2015 to October 2016 were grouped two groups and each with 63 cases.The control group were treated with amlodipine besylate,and observation group was treated with Juming Jiangya pill.The effect of 2 groups of antihypertensive treatment, the influence on related factors and the safety were analyzed.Results (After treatment,total effective rate of observation group was 95.24%,higher than that of control group 80.95%(P<0.05).(After treatment,SBP and DBP level of observation group[were(128.5±6.3),(78.4±5.2)mmHg],lower than that of control group[(140.2±7.5),(88.7±5.5)mmHg](all P<0.05).③After treatment,plasma NO and serum ET level of observation group were[(70.16±5.51)μmol/L,(66.24±5.40)ng/L],better than that of control group[(64.16±5.33)μmol/L,(73.05±5.68)ng/L)](all P<0.05).④During treatment,proportion of adverse reactions of control group was 11.11%,higher than that of observation group 4.76%,difference was not statistically significant.Conclusion Juming Jiangya pill combined with amlodipine besylate have better curative effect and medication safety.
